Riskpilot← Back to searchSign inGet full accessImmumap Services ApS
APSBankruptCVR 38169866Agern Alle 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 20163 employeeswww.immumap.com
Revenue 2020
DKK 521K
-23% vs 2019
EBITDA margin
-211.6%
-21% vs 2019
Equity ratio
-970.3%
Financial strength
Net profit 2020
DKK -1,3M
-24% vs 2019
| Revenue | DKK 521K | -23% |
| EBITDA | DKK -1,1M | -21% |
| Net profit | DKK -1,3M | -24% |
| Total assets | DKK 363K | -37% |
| Equity | DKK -3,5M | -57% |
| Employees | 3 | — |
Legal name
Immumap Services ApS
CVR number
38169866
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. november 2016
Share capital
DKK 62.500
Employees
3 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2020-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er som en contract research organization (CRO) at udføre immunomonitorerings- og epitop discovery service med avancerede immunologiske målinger, samt, efter ledelsens skøn, hermed beslægtet virksomhed.
Address
Agern Alle 3
Phone
+4561781882
Email
tmf@immumap.com
Website
www.immumap.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Revenue | -318 | 1.402 | 674 | 521 |
| Staff expenses | -904 | -1.299 | -1.582 | -1.623 |
| EBITDA | -1.222 | 103 | -908 | -1.102 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -1.222 | 103 | -908 | -1.102 |
| Net financials | -51 | -106 | -128 | -179 |
| Profit before tax | -1.273 | -3 | -1.037 | -1.282 |
| Tax | -26 | -0 | -0 | -0 |
| Net profit | -1.247 | -3 | -1.037 | -1.282 |
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Total assets | 256 | 1.006 | 575 | 363 |
| Equity | -1.197 | -1.200 | -2.237 | -3.519 |
| Long-term debt | 1.251 | 1.957 | 2.562 | 3.375 |
| Short-term debt | 202 | 250 | 250 | 506 |
| Total debt | 1.453 | 2.207 | 2.812 | 3.881 |
EBITDA margin
-211.6%
This company
15.8%
Market median
-1439% vs market
20172020
Equity ratio
-970.3%
This company
38.2%
Market median
-2640% vs market
20172020
Return on equity
-128156200.0%
This company
18.4%
Market median
-696501187% vs market
20172020
Net profit margin
-246.0%
This company
8.1%
Market median
-3137% vs market
20172020
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20172020
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20172020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-11-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HP Management | Management | 2022 | — | — |
TM Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Pourhassan Petersen Holding ApS | Company | 15.0% | 15.0% | 2021 |
Hadrup BioMed Holding ApS | Company | 15.0% | 15.0% | 2021 |
MOLIOR HOLDING ApS | Company | 15.0% | 15.0% | 2021 |
TM Frøsig Invest ApS | Company | 15.0% | 15.0% | 2021 |
Friis Schack Invest ApS | Company | 10.0% | 10.0% | 2021 |
Firkløver Holding ApS | Company | 10.0% | 10.0% | 2021 |
VIGGO HARBOE 2006 HOLDING ApS | Company | 5.0% | 5.0% | 2021 |
GUNNERSEN MARKER HOLDING ApS | Company | 5.0% | 5.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Friis Schack Invest ApS
Immumap Services ApS Board members of Immumap Services ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Houman Pourhassan | Management | 0 companies |
| Thomas Mørch Frøsig | Management | 0 companies |
| Jørgen Schøller | Board of Directors | 0 companies |
| Sine Hadrup | Board of Directors | 0 companies |
| Jeppe Ragnar Andersen | Board of Directors | 0 companies |
| Jan Friis Schack | Board of Directors | 0 companies |
| Søren Elmann Ingerslev | Chairman | 0 companies |